Negev Capital
Overview
Negev Capital is a venture capital firm that invests in early-stage companies developing novel drugs and medical interventions based on psychedelic compounds for neuropsychiatric disorders. The firm focuses on companies in the pre-clinical and Phase 1 stages of development, aiming to support the responsible, medical use of psychedelic medication. Their first fund, "Fund One", closed at over $30 million and is fully invested across 27 companies. The firm targets companies in the USA, Canada, Europe, and Israel.
Portfolio Companies
9
Website
negevcap.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Delix Therapeutics | Sep 2021 | Series A | Co-investor |
| Gilgamesh Pharma Inc. | Dec 2022 | Series B | Co-investor |
| Xylo Bio | Oct 2022 | Seed | Co-investor |
| Mindstate Design Labs | Feb 2022 | Seed | Co-investor |
| Ozlo Sleep | Aug 2023 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
George Kikvadze
Limited Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Negev Capital based?
Negev Capital is headquartered in Cayman Islands.
When was Negev Capital founded?
Founding year information for Negev Capital is not publicly available.
How many portfolio companies does Negev Capital have?
Negev Capital has 9 portfolio companies in Caplight's dataset.
What are some companies in Negev Capital's portfolio?
Portfolio companies visible on Caplight include Delix Therapeutics, Gilgamesh Pharma Inc., Xylo Bio, Mindstate Design Labs, Ozlo Sleep.
What was Negev Capital's most recent investment shown here?
Negev Capital's most recent investment in this portfolio sample was in Ozlo Sleep in 2023.
What sectors does Negev Capital focus on?
Negev Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Negev Capital focus on?
Negev Capital typically invests at the Early stage.
What is Negev Capital's AUM?
Negev Capital's assets under management are estimated between $30.0M and $31.0M.